Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma

British Journal of Haematology

Volumn 99, Issue 2, 1997, Pages 368-371

  Dhodapkar, Madhav V ^a,b   Kelly, Thomas ^a   Theus, Allison ^a   Athota, Anupama B ^a   Barlogie, Barthel ^a   Sanderson, Ralph D ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b NONE   (United States)

Author keywords

Metalloproteinase; Myeloma; Proteoglycan; Syndecan

Indexed keywords

BETA 2 MICROGLOBULIN; GELATINASE B; PARAPROTEIN; SYNDECAN;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; PLASMACYTOSIS; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0030722012     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3893203.x     Document Type: Article

References (11)

1. Barlogie, B. (1995) Plasma cell myeloma. Williams' Textbook of Hematology (ed. by E. Beutler, M. A. Lichtman, B. S. Coller and T. J. Kipps), pp. 1109-1126. McGraw Hill, New York.
2. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L. & Lose, E.J. (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology, 8, 365-393.
3. Borset, M., Helseth, E., Naume, B. & Waage, A. (1993) Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation. British Journal of Haematology, 85, 446-451.
4. Heussen, C. & Dowdle, E.B. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerized substrates. Analytical Biochemistry, 102, 196-202.
5. Liebersbach, B.F. & Sanderson, R.D. (1994) Expression of syndecan-1 inhibits cell invasion into type I collagen. Journal of Biological Chemistry, 269, 20013-20019.
6. Ridley, R.C., Xiao, H., Hata, H., Woodliff, J., Epstein, J. & Sanderson, R.D. (1993) Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood. 81, 767-774.
7. Sanderson, R.D., Lalor, P. & Bernfield, M. (1989) B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regulation, 1, 27-35.
8. Stanley, M.J., Liebersbach, B.J., Liu, W., Anhalt, D.F. & Sanderson, R.D. (1995) Heparan sulfate-mediated cell aggregation: syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. Journal of Biological Chemistry, 270, 5077-5083.
9. Stetler-Stevenson, W., Liotta, L.A. & Kleiner, D.E. (1993) Extra-cellular matrix 6: role of matrix metalloproteinases in tumour invasion and metastasis. FASEB Journal, 7, 1434-1441.
10. Wijdenes, J., Voois, W.C., Clement, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R.X., Klein, B. & Dore, J.M. (1996) A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. British Journal of Haematology, 94, 318-323.
11. r 92,000 type IV collagenase is increased in the plasma of patients with colon and breast cancer. Cancer Research, 53, 140-146.